SXT SMART XROSS-LINKING TECHNOLOGY
DEAD

Serial Number

79357359

Owner

MATEX LAB SWITZERLAND SA

Filing Date

Jun 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SXT SMART XROSS-LINKING TECHNOLOGY Trademark

Serial Number: 79357359

SXT SMART XROSS-LINKING TECHNOLOGY is a trademark filed by MATEX LAB SWITZERLAND SA on June 9, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

MATEX LAB SWITZERLAND SA (4 trademarks)

Route de la Galaise 12

Entity Type: 98

Trademark Details

Filing Date

June 9, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceuticals; dietetic foods adapted for medical purposes; dietetic substances adapted for medical use; dietary supplements for humans; amino acids for medical purposes; albumin dietary supplements; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; chemico-pharmaceutical preparations; moist wipes impregnated with a pharmaceutical lotion; disinfectants for hygiene purposes; pharmaceuticals; acids for pharmaceutical purposes; medicinal infusions; balms for pharmaceutical purposes; mineral dietary supplements; eyepatches for medical purposes; medical preparations for slimming purposes; diet capsules; slimming pills; food supplements; pomades for medical purposes; pharmaceutical preparations for skin care; skin relief serum [medicated]; skin calming serum [medicated]; antitoxic sera; antioxidant pills; medicinal hair growth preparations; medicinal hair growth preparations; medicinal hair growth preparations; disinfectants; washes (disinfectant -) [other than soap]; hand-sanitizing preparations; antiseptic washing preparations; disinfectants and antiseptics; medical preparations; pharmaceutical preparations and products, pharmacological preparations, pharmacological preparations, chemical products and preparations all for medical purposes; pharmaceutical preparations and products, pharmacological preparations and pharmacological preparations and chemical products and preparations for use in the following fields: medical aesthetics and skin care (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); cosmeceuticals, all for medical purposes or for therapeutic purposes; skin care preparations for medical use; dermatological preparations, dermatological preparations; skin lotion (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations), medicated skin creams, skin tonics for medical purposes, medicated skin care preparations, medical preparations for skin care sold exclusively in: medical clinics, medical aesthetics clinics, beauty clinics and plastic surgery clinics and in medical spas and aesthetic medicine practices; pharmaceuticals, pharmacological preparations, chemical preparations, the aforesaid goods sold in filled syringes (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); filled syringes, for medical use; injectable dermal fillers; dermatological and pharmaceutical products injected into or under the skin, into or under mucous membranes for filling, remodelling, giving volume to any part of the human body or for skin moisturising; filled syringes for medical purposes [containing pharmaceuticals]; chemical preparations for medical purposes; pre-filled syringes for medical purposes; dermal fillers

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 2, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 29, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 29, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 27, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 8, 2024 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 28, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 28, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 28, 2023 ABN2
REFUSAL PROCESSED BY IB
Jun 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 29, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 28, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 16, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 8, 2022 REPR